![Janet Loesberg](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Janet Loesberg
Technik-/Wissenschafts-/F&E-Leiter bei BLUEPRINT MEDICINES CORPORATION
Aktive Positionen von Janet Loesberg
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
BLUEPRINT MEDICINES CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2020 | - |
AMBRX INC | Direktor/Vorstandsmitglied | 01.06.2022 | - |
Ambrx Biopharma, Inc.
![]() Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | Direktor/Vorstandsmitglied | 02.06.2022 | - |
Independent Dir/Board Member | - | - | |
All In Together Campaign, Inc. | Direktor/Vorstandsmitglied | - | - |
The Loesberg Group LLC | Präsident | - | - |
Karriereverlauf von Janet Loesberg
Ehemalige bekannte Positionen von Janet Loesberg
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Janssen Pharmaceuticals, Inc.
![]() Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2019 | 01.03.2020 |
Ausbildung von Janet Loesberg
University of Michigan | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 8 |
Operativ
Director/Board Member | 4 |
Independent Dir/Board Member | 2 |
Chief Tech/Sci/R&D Officer | 2 |
Sektoral
Health Technology | 5 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
BLUEPRINT MEDICINES CORPORATION | Health Technology |
Private Unternehmen | 5 |
---|---|
Janssen Pharmaceuticals, Inc.
![]() Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Health Technology |
Ambrx, Inc.
![]() Ambrx, Inc. Pharmaceuticals: MajorHealth Technology Ambrx, Inc. engages in discovering and developing of protein therapeutics. It offers non-native amino acids through expanded genetic code to both generate novel bio-therapeutics. The company was founded by Richard DiMarchi, Peter G. Schultz, and Troy E. Wilson on April 15, 2003 and is headquartered in La Jolla, CA. | Health Technology |
All In Together Campaign, Inc. | |
Ambrx Biopharma, Inc.
![]() Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | Health Technology |
The Loesberg Group LLC |
- Börse
- Insiders
- Janet Loesberg
- Erfahrung